Increased lipoproteins and fibrinogen in chronic renal allograft dysfunction.

被引：0
|
作者：
Fernández-Miranda, C
de Bustillo, EM
Morales, JM
Porres, A
Gomez-Gerique, J
Guijarro, C
Aranda, JL
Andrés, A
Rodicio, JL
Del Palacio, A
机构：
[1] Hosp 12 Octubre, Med Interna Serv, Unidad Lipidos, FJD, E-28041 Madrid, Spain
[2] Hosp 12 Octubre, Serv Nefrol, Unidad Lipidos, FJD, E-28041 Madrid, Spain
来源：
KIDNEY INTERNATIONAL | 1999年 / 55卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：374 / 374
页数：1
相关论文
共 50 条
  • [1] Increased lipoproteins and fibrinogen in chronic renal allograft dysfunction
    FernandezMiranda, C
    Morales, JM
    Porres, A
    GomezGerique, J
    Guijarro, C
    Aranda, JL
    Andres, A
    Rodicio, JL
    DelPalacio, A
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1997, 17 (05) : 445 - 449
  • [2] Increased lipoproteins and fibrinogen in chronic renal allograft rejection
    FernandezMiranda, C
    Morales, JM
    Guijaro, C
    Aranda, JL
    Porres, A
    GomezGerique, J
    [J]. ATHEROSCLEROSIS, 1997, 134 (1-2) : 43 - 43
  • [3] Tubular epithelial cell to fibroblast transition in chronic renal allograft dysfunction.
    Kirby, JA
    Robertson, H
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 274 - 274
  • [4] Increased Risk for Allograft Loss in African American Kidney Transplant Recipients After Biopsy for Chronic Allograft Dysfunction.
    Dorr, C. R.
    Wu, B.
    Guo, B.
    Guan, W.
    Schladt, D.
    Elmer, S.
    Crary, G.
    Onyeaghala, G.
    Oetting, W.
    Agarwal, G.
    Mannon, R. B.
    Jacobson, P.
    Matas, A.
    Israni, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1114 - 1115
  • [5] Human polyoma virus causing renal allograft dysfunction.
    Geetha, D
    Talusan, Y
    Racusen, L
    Ratner, L
    Burdick, J
    Montgomery, R
    Maley, W
    Kraus, E
    Markowitz, J
    [J]. TRANSPLANTATION, 2000, 69 (08) : S387 - S387
  • [6] Indirect allorecognition of MHC peptides in human renal allograft recipients with chronic graft dysfunction.
    Vella, JP
    Murphy, B
    Alexander, S
    Sayegh, MH
    Carpenter, CB
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3258 - A3258
  • [7] Chronic renal allograft dysfunction
    Chapman, JR
    O'Connell, PJ
    Nankivell, BJ
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (10): : 3015 - 3026
  • [8] Low-Dose Interleukin-2 Therapy: Effects in Chronic Renal Allograft Dysfunction.
    Schachtner, T.
    Stein, M.
    Sattler, A.
    Landwehr-Kenzel, S.
    Sawitzki, B.
    Reinke, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 475 - 476
  • [9] Low-Dose Interleukin-2 Therapy: Effects in Chronic Renal Allograft Dysfunction.
    Schachtner, T.
    Stein, M.
    Sattler, A.
    Landwehr-Kenzel, S.
    Sawitzki, B.
    Reinke, P.
    [J]. TRANSPLANTATION, 2014, 98 : 475 - 476
  • [10] The significance of luminex testing in renal transplant recipients with allograft dysfunction.
    Qazi, Yasir A.
    Cicciarelli, James
    Hermes, Mark
    Smogorzewski, Miroslaxv
    Koss, Michael
    Sher, Linda
    Selby, Robert R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 355 - 355
12345